Health Care Barriers Contribute to Delays in Follow-Up Screening for Women With Cancer
the ONA take:
Researchers performed secondary analyses of data from the intervention arms of the Patient Navigation Research Program to gain a better understanding of the association between barriers to care and clinical outcomes within patient navigation programs.
The data included navigated participants with abnormal breast and cervical cancer screening test results from 2007 to 2010.
The researchers considered the number of unique barriers (0, 1, 2, ≥3) documented during patient navigation encounters and the presence of socio-legal barriers originating from social policy (yes/no).
Approximately 75% of 2,600 breast screening participants and more than one-half of 1,387 cervical screening participants had barriers to care documented.
Any number of barriers was associated with less timely resolution among breast cancer participants compared with those who had no barriers documented; however, only the presence of two or more barriers was associated with less timely resolution among cervical screening participants.
The study findings demonstrated that barriers to care resulted in less timely resolution of abnormal screening results among navigated women.
The researchers conclude further innovations are needed to improve the impact of patient navigation programs nationwide.
A better understanding of the association between barriers to care and clinical outcomes within patient navigation programs.
- Immunotherapy May Benefit Some Patients with Papillary Thyroid Carcinoma
- New Study Questions Standard Dosage for Treating Metastatic Non-Small Cell Lung Cancer
- Clinical Trials May Benefit Oncology Patients
- Breast Cancer Overdiagnosis Also a Result of Screening Mammography Programs
- Prostate-specific PET and CT Imaging Improves Detection of Disease and Patient Care
- Survivorship Care Plans: Providing A Blueprint for Health Care After Cancer
- Multifaceted Role of the Nurse Navigator Includes Palliative, Supportive Care
- Cancer Recurrence Fear Reduced by Novel Psychological Intervention
- Patient Navigators Found to Boost Lung Cancer Screening Rates
- Breast Cancer Diagnosis and Nurse Navigation Survey
- Novel 3D Marker Reduces Radiation, Improves Cosmesis in Breast Conserving Surgery
- Rates at Some Milestones May Indicate Clinical Trial Results for Immunotherapeutics
- Cancer Risks for BRCA1/2 Mutation Carriers Determined by Age, Family History, Mutation Location
- Long-Term Use of TPO Receptor Agonist Safe in CLL-Associated Immune Thrombocytopenia
- Savolitinib Active, Tolerable in Subset of Advanced Papillary Renal Cell Cancer
Sign Up for Free e-newsletters
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|